Royal Bank of Canada’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

Royal Bank of Canada’s Portfolio NTGN Stock Details NTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-770	Closed	-$2K	–	7168
2020 Q1	$2K	Sell	770 -709	-48%	-$1.16K	﹤0.01%	6384
2019 Q4	$2K	Buy	1,479 +1,236	+509%	+$1.98K	﹤0.01%	6608
2019 Q3	$0	Buy	+243	New	+$739	﹤0.01%	7386
2019 Q1	–	Sell	-107	Closed	-$1K	–	7281
2018 Q4	$1K	Sell	107 -207	-66%	-$1.45K	﹤0.01%	6660
2018 Q3	$2K	Buy	+314	New	+$3.48K	﹤0.01%	6559

Royal Bank of Canada's NTGN Position: Q2 2020 in Review

Royal Bank of Canada sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q2 2020, closing a stake of 770 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in NTGN in Q3 2018 and held it in 5 quarters. The position peaked at $2K in Q1 2020. 0 funds tracked by Wall St. Rank hold NTGN as of Q2 2020.

Royal Bank of Canada reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Royal Bank of Canada sold 770 Neon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $2K.
Royal Bank of Canada first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Royal Bank of Canada's Neon Therapeutics, Inc. Common Stock position peaked at $2K in Q1 2020.
0 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Royal Bank of Canada's 13F filing for Q2 2020, filed 14 Aug 2020.